An Act to Establish Additional Requirements for Dentists to Administer Botulinum Toxin and Dermal Fillers
Summary
LD 1374 would add new statutory requirements for dentists in Maine who want to administer botulinum toxin (such as Botox) or dermal fillers. The bill allows dentists to provide these treatments only when they are tied to a diagnosed dental condition or included in a patient’s dental treatment plan, and it also preserves a narrower pathway for dentists with advanced oral and maxillofacial surgery training to use these substances in treating oral or maxillofacial disease, disfigurement, or disjunction.
The bill further requires dentists to complete approved continuing education or other board-approved training before administering botulinum toxin or dermal fillers. For each substance, the training must include at least 8 hours covering head and neck anatomy, neurophysiology, patient selection, pharmacological effects and contraindications, complication management, informed consent, and hands-on administration. Before treatment, the dentist must obtain the patient’s medical and dental history, perform a clinical examination, and secure informed consent.
Impact
If enacted, the bill would amend Maine’s dental practice laws to create explicit education, training, and patient-evaluation requirements for dentists administering botulinum toxin or dermal fillers. It would affect the scope of dental practice by limiting these procedures to dental conditions or treatment plans and by setting a higher qualification standard for dentists who wish to perform them. The measure would primarily affect dentists, dental boards, and patients receiving cosmetic or therapeutic facial injections in a dental setting.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes, the available record suggests a neutral-to-supportive regulatory approach rather than a clearly controversial one. The bill appears aimed at patient safety, professional standards, and clarifying when dentists may perform these procedures. Because no committee discussion or voting history is provided, there is no documented public opposition or support in the materials supplied.
Contention
The main policy issue is whether dentists should be allowed to administer botulinum toxin and dermal fillers, and if so, under what conditions. Potential points of contention include the scope of dental practice, whether the required 8 hours of training is sufficient, and whether the bill appropriately distinguishes between general dentists and those with advanced oral and maxillofacial surgery training. Another possible issue is the boundary between therapeutic dental use and cosmetic facial procedures, since the bill limits use to diagnosed dental conditions or dental treatment plans.